Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Clinical trial NCT00857818 · TERMINATED

Trial details

NCT number: NCT00857818
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar I Disorder Metabolic Syndrome

Start date: 2009-04-01
Primary completion: 2010-03-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.